[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-119105-en":3,"doc-seo-119105-105":30,"detail-sidebar-cat-0-en-105":91},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":4,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"site_id":24,"html_lang":23,"table_of_contents":25,"faqs":26,"seo_title":27,"seo_description":14,"update_tm":28,"read_time":29},119105,2336464648322,"Aria","https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488",8,"Research & Report","Machine Learning in Drug Discovery - Applications, Challenges, and Future Directions","Machine learning has transformed drug discovery by accelerating workflows and improving the quality of therapeutic research. The analysis reviews how machine learning supports compound screening and virtual screening by evaluating large chemical libraries, and extends to QSAR modeling, predictive ADMET modeling, de novo drug design, and target identification and validation. It also examines key obstacles including data quality and quantity, interpretability, the need to align domain knowledge with data-driven methods, and limits in transferability and generalization, alongside ethical and regulatory requirements. Finally, it forecasts progress toward explainable AI, multi-modal integration, reinforcement learning for optimization, collaborative AI platforms, and stronger governance.","INTERNATIONAL JOURNAL ON ORANGE TECHNOLOGY  \n[https://journals.researchparks.org/index.php/IJOT](https://journals.researchparks.org/index.php/IJOT) e-ISSN: 2615-8140 | p-ISSN: 2615-7071 Volume: 5 Issue: 8 | Aug 2023  \nMachine Learning in Drug Discovery: A Comprehensive Analysis of Applications,  \nChallenges, and Future Directions  \nArjun Reddy Kunduru  \nIndependent Researcher, Orlando, FL, USA  \n***  \n----- - ---------------------- ------ ---------------------------- ----------------- ------ ----- -- -------------------------------  \nAnnotation: Machine learning has revolutionized drug discovery by speeding up the process and improving therapeutic interventions, transforming the pharmaceutical research and development landscape.  \nThe paper embarks on a meticulous journey, delving into the intricate fabric of machine learning's integration into drug discovery. It deftly navigates through the virtual corridors of compound screening and virtual screening, where machine learning algorithms intricately assess massive chemical libraries, substantially hastening the identification of potential drug candidates. The analysis extends to encompass quantitative structure-activity relationship (QSAR) modeling, predictive ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) modeling, de novo drug design, and target identification and validation, meticulously unraveling the pivotal role machine learning plays in each facet.  \nYet this transformative union does not come without its share of challenges. The paper uncovers the nuances of data quality and quantity, grapples with the intricacies of interpretability, and addresses the critical need to harmonize domain knowledge with data-driven methodologies. It illuminates the hurdles of transferability and generalization, coupled with the ethical and regulatory considerations that loom large over this cutting-edge convergence.  \nFurthermore, this paper casts an anticipatory glance toward the future horizons of this symbiotic relationship between machine learning and drug discovery. It envisions a time when there will be explainable AI, multi-modal data integration, reinforcement learning for compound optimization, collaborative AI platforms, and strong ethical and regulatory frameworks. By synthesizing insights gleaned from a systematic review of existing literature, this paper aims to spotlight the profound metamorphosis that machine learning has ushered into the realm of drug discovery, underscoring its pivotal role in revolutionizing, and reshaping the contours of pharmaceutical research.  \nKeywords: Machine Learning, Drug Discovery, Cloud Computing, Advance Applications.  \n1. Introduction:  \nThe journey of drug discovery, intricate and protracted, encompasses the discernment, conception, and refinement of novel therapeutic agents to combat an array of ailments. In this intricate tapestry, the infusion of machine learning methods has emerged as a transformative force, heralding a new era in drug discovery methodologies. This partnership has made a huge change in the way drug research is done. It has made it easier to find potential drug candidates, more accurate to predict molecular properties, and more precise to optimize lead compounds.  \nThis paper stands as a beacon, aiming to unravel the intricacies of this amalgamation. Its intent is to unravel the expansive tapestry woven by machine learning within drug discovery—an assemblage of capabilities that spans the spectrum from efficient candidate identification to the foresight of molecular characteristics and the finetuning of pivotal lead compounds. Yet, as with any transformative journey, challenges emerge. The paper, poised at the cusp of innovation, delves into these intricacies, scrutinizing hurdles that span from data-driven conundrums to the imperative of ethical and regulatory considerations.  \nINTERNATIONAL JOURNAL ON ORANGE TECHNOLOGY  \n[https://journals.researchparks.org/index.php/IJOT](https://journals.research","cbCaii8IyFBuez7o","https://ap.wps.com/l/cbCaii8IyFBuez7o","pdf",550800,1,9,"English","en",105,"# Introduction\n## Applications of Machine Learning in Drug Discovery\n### Compound Screening and Virtual Screening","[{\"question\":\"How does machine learning improve compound screening and virtual screening in drug discovery?\",\"answer\":\"Machine learning algorithms use computational screening to rapidly sift through large chemical libraries, detect patterns, and predict compound–drug interactions, speeding up identification of candidate drugs.\"},{\"question\":\"What roles do QSAR and predictive ADMET models play in this field?\",\"answer\":\"QSAR modeling helps relate molecular structure to activity, while predictive ADMET modeling estimates absorption, distribution, metabolism, excretion, and toxicity to support safer, more effective candidate selection.\"},{\"question\":\"What challenges must be addressed for machine learning to be effective in drug discovery?\",\"answer\":\"Key challenges include limited or uneven data quality and quantity, interpretability concerns, difficulties balancing domain knowledge with data-driven approaches, and issues with transferability, generalization, and ethical/regulatory compliance.\"}]","Machine Learning in Drug Discovery - Applications, Challenges, and Future Directions | PDF",1785722409,23,{"code":4,"msg":31,"data":32},"ok",{"site_id":24,"language":23,"slug":33,"title":13,"keywords":34,"description":14,"schema_data":35,"social_meta":86,"head_meta":88,"extra_data":90,"updated_unix":28},"machine-learning-in-drug-discovery-applications-challenges-and-future-directions","",{"@graph":36,"@context":85},[37,54,68],{"@type":38,"itemListElement":39},"BreadcrumbList",[40,44,48,51],{"item":41,"name":42,"@type":43,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":45,"name":46,"@type":43,"position":47},"https://docshare.wps.com/document/","Document",2,{"item":49,"name":12,"@type":43,"position":50},"https://docshare.wps.com/document/research-report/",3,{"item":52,"name":13,"@type":43,"position":53},"https://docshare.wps.com/document/machine-learning-in-drug-discovery-applications-challenges-and-future-directions/119105/",4,{"url":52,"name":13,"@type":55,"author":56,"headline":13,"publisher":58,"fileFormat":61,"inLanguage":23,"description":14,"dateModified":62,"datePublished":62,"encodingFormat":61,"isAccessibleForFree":63,"interactionStatistic":64},"DigitalDocument",{"name":9,"@type":57},"Person",{"url":41,"name":59,"@type":60},"DocShare","Organization","application/pdf","2026-08-03",true,{"@type":65,"interactionType":66,"userInteractionCount":4},"InteractionCounter",{"@type":67},"ViewAction",{"@type":69,"mainEntity":70},"FAQPage",[71,77,81],{"name":72,"@type":73,"acceptedAnswer":74},"How does machine learning improve compound screening and virtual screening in drug discovery?","Question",{"text":75,"@type":76},"Machine learning algorithms use computational screening to rapidly sift through large chemical libraries, detect patterns, and predict compound–drug interactions, speeding up identification of candidate drugs.","Answer",{"name":78,"@type":73,"acceptedAnswer":79},"What roles do QSAR and predictive ADMET models play in this field?",{"text":80,"@type":76},"QSAR modeling helps relate molecular structure to activity, while predictive ADMET modeling estimates absorption, distribution, metabolism, excretion, and toxicity to support safer, more effective candidate selection.",{"name":82,"@type":73,"acceptedAnswer":83},"What challenges must be addressed for machine learning to be effective in drug discovery?",{"text":84,"@type":76},"Key challenges include limited or uneven data quality and quantity, interpretability concerns, difficulties balancing domain knowledge with data-driven approaches, and issues with transferability, generalization, and ethical/regulatory compliance.","https://schema.org",{"og:url":52,"og:type":87,"og:title":13,"og:site_name":59,"og:description":14},"article",{"robots":89,"canonical":52},"index,follow",{"doc_id":7,"site_id":24},{"code":4,"msg":5,"data":92},[93,97,101,105,110,115,120,123,127,130,134],{"id":20,"doc_module":4,"doc_module_name":46,"category_name":94,"show_sort_weight":95,"slug":96},"Story & Novel",90,"story-novel",{"id":47,"doc_module":4,"doc_module_name":46,"category_name":98,"show_sort_weight":99,"slug":100},"Literature",80,"literature",{"id":53,"doc_module":4,"doc_module_name":46,"category_name":102,"show_sort_weight":103,"slug":104},"Exam",70,"exam",{"id":106,"doc_module":4,"doc_module_name":46,"category_name":107,"show_sort_weight":108,"slug":109},5,"Comic",60,"comic",{"id":111,"doc_module":4,"doc_module_name":46,"category_name":112,"show_sort_weight":113,"slug":114},6,"Technology",50,"technology",{"id":116,"doc_module":4,"doc_module_name":46,"category_name":117,"show_sort_weight":118,"slug":119},7,"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":46,"category_name":12,"show_sort_weight":121,"slug":122},30,"research-report",{"id":21,"doc_module":4,"doc_module_name":46,"category_name":124,"show_sort_weight":125,"slug":126},"Religion & Spirituality",20,"religion-spirituality",{"id":125,"doc_module":4,"doc_module_name":46,"category_name":128,"show_sort_weight":125,"slug":129},"World Cup","world-cup",{"id":131,"doc_module":4,"doc_module_name":46,"category_name":132,"show_sort_weight":131,"slug":133},10,"Lifestyle","lifestyle",{"id":135,"doc_module":4,"doc_module_name":46,"category_name":136,"show_sort_weight":106,"slug":137},19,"General","general"]